Related Experiment Videos
Evaluation studies on the in vitro rat hepatocyte micronucleus assay
K Müller-Tegethoff1, P Kasper, L Müller
1Federal Institute for Drugs and Medical Devices, Berlin, Germany.
Mutation Research
|December 1, 1995
Summary
The in vitro rat hepatocyte micronucleus assay accurately identified genotoxic profiles for 90% of tested chemicals, distinguishing isomers and confirming non-genotoxicity of some hepatocarcinogens. However, it is not recommended for general genotoxicity screening.
Area of Science:
- Toxicology and Pharmacology
- In Vitro Assays
- Genotoxicity Testing
Background:
- The in vitro rat hepatocyte micronucleus assay is a tool for assessing chemical genotoxicity.
- Previous studies established a baseline with 8 chemicals, necessitating further validation with diverse compounds.
Purpose of the Study:
- To evaluate the applicability of the in vitro rat hepatocyte micronucleus assay for genotoxicity testing.
- To assess the assay's accuracy with a broader range of chemical classes and known genotoxic/non-genotoxic profiles.
Main Methods:
- Testing of 21 additional chemical compounds using the in vitro rat hepatocyte micronucleus assay.
- Comparison of assay results with established genotoxic profiles of tested chemicals.
- Analysis of specific chemical classes including alkylating agents, aromatic amines, nitro compounds, and polycyclic aromatic hydrocarbons.
Main Results:
- The assay demonstrated good agreement (approx. 90%) with known genotoxic profiles.
- Positive results were observed for known mutagens and carcinogens; negative results for non-carcinogens.
- The assay distinguished between carcinogenic isomers (e.g., AAF, NP) and confirmed the non-genotoxicity of certain hepatocarcinogens (e.g., DEHP, phenobarbital).
- Known carcinogens benzo[a]pyrene (B[a]P) and 7,12-dimethylbenzanthacene (DMBA) yielded negative results due to cytotoxic effects causing mitotic inhibition.
Conclusions:
- The in vitro rat hepatocyte micronucleus assay is valuable for specific applications, particularly for detecting liver-specific mutagenic effects.
- It is not currently recommended for broad screening of genotoxicity due to limitations with cytotoxic compounds.
- Further research may refine its utility for specialized toxicological assessments.